Market Data
MarketsJazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress
Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress
Related Articles
Why you shouldn’t blame AI for the weak jobs data
neutral
MarketWatchabout 2 hours ago
Liquidity Stress in HY Bond Market: Gomez-Bravo
bearish
Bloombergabout 2 hours ago
Hedge Fund Owl Creek Dumped 1.9 Million Shares of Lyft Worth $40.3 Million. Is the Stock a Buy or Sell?
bearish
Yahoo Financeabout 2 hours ago
'Oil North of $100' Would Be Concern: Janet Rilling
bearish
Bloombergabout 2 hours ago
You May Also Like
Why you shouldn’t blame AI for the weak jobs data
MarketWatch•about 2 hours ago
Liquidity Stress in HY Bond Market: Gomez-Bravo
Bloomberg•about 2 hours ago
Hedge Fund Owl Creek Dumped 1.9 Million Shares of Lyft Worth $40.3 Million. Is the Stock a Buy or Sell?
Yahoo Finance•about 2 hours ago
'Oil North of $100' Would Be Concern: Janet Rilling
Bloomberg•about 2 hours ago
Only about 8 ships a day are passing through the Strait of Hormuz — 94% fewer than usual
MarketWatch•about 2 hours ago
S&P 500 changes are due out soon. These AI stocks could join the index.
MarketWatch•about 2 hours ago